Prognostic factors of laryngeal solitary extramedullary plasmacytoma: a case report and review of literature

Int J Clin Exp Pathol. 2015 Mar 1;8(3):2415-35. eCollection 2015.

Abstract

A paucity of data exists concerning the presentation, natural course and outcome of extramedullary plasmcytoma (EMP). It is difficult to determine the optimal treatment strategy and prognostic factors for EMP. We present an additional case of laryngeal EMP and systemic review relevant reports in the English and Chinese literature. We found, to our knowledge, 147 cases in larynx in the English-language literature and Chinese-literature. The most common treatment modality was radiotherapy alone. The mean survival duration was ~184 months, and the 5- and 10- year survival rates were 76.1% and 67.4%, respectively. The univariate analysis suggested that progression to multiple myeloma and amyloid deposits may be poor prognostic factors. The multivariate analysis suggested that only progression to multiple myeloma may be a poor prognostic factor. Laryngeal EMP is uncommon. Progression to multiple myeloma may be a poor prognostic factor.

Keywords: Extramedullary plasmcytoma; amyloid deposits; larynx; prognosis; progression to multiple myeloma.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers, Tumor / analysis
  • Biopsy
  • Diffusion Magnetic Resonance Imaging
  • Disease Progression
  • Dose Fractionation, Radiation
  • Female
  • Humans
  • Immunohistochemistry
  • Laryngeal Neoplasms* / chemistry
  • Laryngeal Neoplasms* / diagnosis
  • Laryngeal Neoplasms* / therapy
  • Laryngoscopy
  • Male
  • Middle Aged
  • Multiple Myeloma* / chemistry
  • Multiple Myeloma* / diagnosis
  • Multiple Myeloma* / therapy
  • Multivariate Analysis
  • Plasmacytoma* / chemistry
  • Plasmacytoma* / diagnosis
  • Plasmacytoma* / therapy
  • Radiotherapy, Adjuvant
  • Risk Factors
  • Stroboscopy
  • Time Factors
  • Tracheostomy
  • Treatment Outcome

Substances

  • Biomarkers, Tumor